Preoperative High-resolution Magnetic Resonance Imaging Can Identify Good Prognosis Stage I, II, and III Rectal Cancer Best Managed by Surgery Alone
Top Cited Papers
- 1 April 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 253 (4) , 711-719
- https://doi.org/10.1097/sla.0b013e31820b8d52
Abstract
To assess local recurrence, disease-free survival, and overall survival in magnetic resonance imaging (MRI)–predicted good prognosis tumors treated by surgery alone. The MERCURY study reported that high-resolution MRI can accurately stage rectal cancer. The routine policy in most centers involved in the MERCURY study was primary surgery alone in MRI-predicted stage II or less and in MRI “good prognosis” stage III with selective avoidance of neoadjuvant therapy. Data were collected prospectively on all patients included in the MERCURY study who were staged as MRI-defined “good” prognosis tumors. “Good” prognosis included MRI-predicted safe circumferential resection margins, with MRI-predicted T2/T3a/T3b (less than 5 mm spread from muscularis propria), regardless of MRI N stage. None received preoperative or postoperative radiotherapy. Overall survival, disease-free survival, and local recurrence were calculated. Of 374 patients followed up in the MERCURY study, 122 (33%) were defined as “good prognosis” stage III or less on MRI. Overall and disease-free survival for all patients with MRI “good prognosis” stage I, II and III disease at 5 years was 68% and 85%, respectively. The local recurrence rate for this series of patients predicted to have a good prognosis tumor on MRI was 3%. The preoperative identification of good prognosis tumors using MRI will allow stratification of patients and better targeting of preoperative therapy. This study confirms the ability of MRI to select patients who are likely to have a good outcome with primary surgery alone.Keywords
This publication has 10 references indexed in Scilit:
- Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trialThe Lancet Oncology, 2010
- Magnetic Resonance Imaging Prediction of an Involved Surgical Resection Margin in Low Rectal CancerDiseases of the Colon & Rectum, 2009
- Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trialThe Lancet, 2009
- Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancerBritish Journal of Surgery, 2008
- Radiation Therapy in Stage II and III Rectal CancerClinical Cancer Research, 2007
- The TME Trial After a Median Follow-up of 6 YearsAnnals of Surgery, 2007
- Extramural Depth of Tumor Invasion at Thin-Section MR in Patients with Rectal Cancer: Results of the MERCURY StudyRadiology, 2007
- Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational studyBMJ, 2006
- MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?British Journal of Cancer, 2006
- Are We Overtreating Rectal Cancer: Time for Another Trial?Annals of Surgical Oncology, 2004